Appetite suppressants withdrawn CMAJ 1997;157:1007 © 1997 Canadian Medical Association Health Canada has warned consumers not to use appetite suppressants containing fenfluramine or dexfenfluramine, prescription drugs used in the short-term treatment of obesity. They are also prescribed in a combination therapy known as fen-phen (fenfluramine and phentermine). The warning was issued Sept. 15, the same day an editorial on the subject appeared in CMAJ (1997;157:705-6 [full text / résumé]). Companies agreed to suspend sales that day because of the high incidence of serious heart valve disease observed in the US in patients who have taken the drugs. Send a letter to the editor responding to this article Envoyez une lettre à la rédaction au sujet de cet article | CMAJ October 15, 1997 (vol 157, no 8) / JAMC le 15 octobre 1997 (vol 157, no 8) |